News | October 22, 2014

Hologic to Highlight 3-D Mammography at RSNA 2014

Offerings will include demonstrations, scientific papers and training opportunities

October 22, 2014 — With over 2,000 systems installed worldwide and interest in 3-D technology growing exponentially, a significant focus of Hologic’s exhibit at the 2014 Radiological Society of North America (RSNA) meeting is on new enhancements to the company’s 3-D Mammography platform.

  1. Genius 3-D Mammography exams.  In October, Hologic launched in the United States the "Genius 3-D Mammography" awareness initiative. The Genius campaign is designed to make it easier for women and referring physicians to ask for and find the most accurate mammography exam available.

  2. Low dose 3-D mammography. The Hologic C-View software option generates 2-D images from a 3-D data set without the need for a 2-D exposure, thus reducing the patient’s radiation dose and time under compression. With C-View software, facilities can offer a better exam at an equivalent dose to 2-D alone. C-View software was CE marked in 2011 and approved for commercial release in the United States in 2013. Currently, over 40 percent of the Selenia Dimensions 3-D systems installed in the United States include the low dose 3-D mammography option.

  3. 3-D guided breast biopsy.  Hologic’s Affirm 3-D mammography biopsy option is designed for the localization and accurate targeting of regions of interest and is especially important for targeting lesions not detected in 2-D imaging or when using other modalities. This new biopsy technique is designed to provide numerous advantages over traditional stereotactic biopsy procedures, including faster lesion targeting and reduced patient procedure time. The Affirm system is pre-programmed for use with the company's Eviva and ATEC vacuum-assisted breast biopsy devices. Launched in the United States in June 2013, this biopsy option is especially valuable for women with breast lesions that are hard to reach with standard biopsy procedures, as well as for women with arthritis or other physical issues that make traditional biopsy difficult.

  4. CAD for generated 2-D images from a 3-D data set. Designed with user input, Hologic’s ImageChecker CAD 10.0 software for C-View 2-D images is now available commercially in the United States and Europe.

  5. Cost-effective screening option with an upgrade path to 3-D. Shown for the first time at RSNA, the Hologic Avia Package is a cost-effective option for customers seeking a 2-D screening-only or 2-D screening and diagnostic solution with a seamless upgrade pathway for interventional and tomosynthesis capabilities. 

  6. Contrast-enhanced 2-D imaging on a 3-D system. Hologic’s new I-View software for Contrast Enhanced 2-D Imaging provides functional imaging information and highly detailed 2-D images for enhanced precision in breast cancer detection. With I-View software, Hologic’s 3-D Mammography images may also be combined with contrast enhanced 2-D images. I-View Contrast Enhanced 2-D Imaging is a simple upgrade to any Selenia Dimensions system, giving breast imaging practices an efficient pathway to expanded diagnostic capabilities. I-View software is CE marked and U.S. Food and Drug Administration (FDA) approved and is now available for clinical use in breast imaging practices.

  7. Over 70 scientific papers, poster sessions and courses on 3-D.  2014 saw the publication of a number of large-scale, clinical studies validating the benefits of Hologic 3-D mammography.  The largest clinical study on the benefits of Hologic 3-D mammography was published in the June 25th issue of the Journal of the America Medical Association (JAMA). The paper received worldwide attention.

    Interest in 3-D mammography remains high with over 70 scientific papers, posters and refresher courses accepted for RSNA. Of particular note are studies on the value of 3-D mammography in women with dense breasts, the impact of generated 2-D images in reducing dose in a 3-D screening exam, screening strategies when the number of 3-D systems is limited, differences in reader performance using 3-D systems, volumetric breast density assessment tool on a 3-D system and recall rate reduction when 3-D exams are used as a part of a breast screening exam. 


  1. Easier and faster ways to obtain FDA-required 3-D training.  Until recently the only way that doctors could obtain the necessary eight hours of training in 3-D was to attend a course or sign up for special webinars on the new technology. Hologic recently launched a new virtual training program which allows doctors to take the training when and where it is most convenient to them. Based on a series of didactic sessions and self-guided clinical case review, Hologic’s virtual 3-D training option can be completed in several segments, eliminating the need for a dedicated block of eight continuous hours of time. Virtual 3-D training will be a featured topic at RSNA this year.


  2. The future of breast biopsy is here. Four times each day from Sunday through Wednesday, experts in the Hologic Innovation Theater will give a presentation on a revolutionary new biopsy system and discuss the future of state-of-the-art prone and upright biopsy solutions from Hologic.


  3. Osteoporosis, cardiovascular disease, body composition and atypical femur fractures assessment on a single platform.  Introduced last year at RSNA 2013, the Horizon DXA system is a single platform to assist clinicians in the assessment of critical health problems – osteoporosis, cardiovascular disease, body composition and atypical femur fractures. Now widely accepted the world over, the new system offers clinicians expanded technical capabilities, workflow efficiencies and improved design components.


But that’s not all. The Hologic exhibit also focuses on new advances in mini C-arm extremity imaging, conventional digital mammography, breast ultrasound, image analytics, and accelerated partial breast irradiation.

For more information: www.hologic.com

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
Breast Cancer Places Greater Financial Burden on Black Women
News | Women's Health | May 16, 2018
Having breast cancer placed a significantly greater financial strain on black women than white women, according to a...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Overlay Init